Outlook Therapeutics (OTLK) Short term Debt (2015 - 2026)
Outlook Therapeutics (OTLK) recorded Short term Debt of $9.85 million in fiscal Q2 2026 (quarter ended Mar 31, 2026), down 18.0% from $12 million a year earlier and down 73.1% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Short term Debt (2015 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics reported Short term Debt of $29.95 million, up 1.7% from FY2024.
- Annual Short term Debt has a five-year compound annual growth rate of 258.9% (FY2020 to FY2025).
- Across earlier fiscal years, Short term Debt came in at $29.44 million in FY2024 (-17.2%), $35.55 million in FY2023 (+225.7%), $10.92 million in FY2022 and $904,200 in FY2021.
- The fiscal Q2 2026 figure is the lowest quarterly Short term Debt since fiscal Q4 2021.
- On a year-over-year basis, Short term Debt rose in two of the last eight quarters, with an average decline of 20.8%.
- Peak year-over-year performance for Short term Debt in the last five years was growth of 232.1% in fiscal Q3 2023, against a decline of 73.2% in fiscal Q2 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $36.66 million (Q1 2026), $29.95 million (Q4 2025) and $14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Outlook Therapeutics | 77.94 Mn | 42.19 Mn | -8,265.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 9.85 Mn |
| Dec 31, 2025 | 36.66 Mn |
| Sep 30, 2025 | 29.95 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 12.00 Mn |
| Dec 31, 2024 | 30.74 Mn |
| Sep 30, 2024 | 29.44 Mn |
| Jun 30, 2024 | 32.43 Mn |
| Mar 31, 2024 | 44.75 Mn |
| Dec 31, 2023 | 36.54 Mn |
| Sep 30, 2023 | 35.55 Mn |
| Jun 30, 2023 | 34.73 Mn |
| Mar 31, 2023 | 31.82 Mn |
| Sep 30, 2022 | 10.92 Mn |
| Jun 30, 2022 | 10.46 Mn |
| Mar 31, 2022 | 22.78 Mn |
| Dec 31, 2021 | 12.72 Mn |
| Sep 30, 2021 | 904,200.00 |
| Jun 30, 2021 | 11.55 Mn |
| Mar 31, 2021 | 11.18 Mn |
API Access
Outlook Therapeutics Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();